Biopharmas raising money in public or private financings, including: Adma, Atara, Cel-Sci, Curis, Edgewise, Forma, Frazier Lifesciences, Hookipa, IGM, Kura, Pepgen, Qu, Reneo, Rocket, Sigilon, Silverback, Sutro, Syndax, Syros, Xphyto.